Drug profile · INN
levacetylmethadol
ORLAAM
levacetylmethadol (ORLAAM) is a mu opioid receptor agonist.
EMA: withdrawn Nervous system (N02) N02AC
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — levacetylmethadol
- Class
- Nervous system (N02)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
levacetylmethadol (ORLAAM) is a mu opioid receptor agonist.
Key facts
INN levacetylmethadol
Brand ORLAAM
Mechanism Mu opioid receptor agonist
Target Mu-type opioid receptor
Therapeutic class Nervous system (N02)
ATC code N02AC
Mechanism of action
Mu opioid receptor agonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is levacetylmethadol?
levacetylmethadol (ORLAAM) is a mu opioid receptor agonist.
What is the brand name for levacetylmethadol?
ORLAAM is a marketed brand name for levacetylmethadol. Check FDA Drugs@FDA for the current US label holder and prescribing information.